AI-Powered Oncology: Transforming Cancer Care Through Data-Driven Medicine

Abstract

Artificial intelligence (AI) is transforming modern oncology by enabling data-driven approaches to cancer prevention, diagnosis, prognosis, treatment planning, therapeutic monitoring, and survivorship care. The exponential growth of biomedical data generated from medical imaging, digital pathology, genomic sequencing, transcriptomics, proteomics, liquid biopsy, wearable technologies, and electronic health records has created unprecedented opportunities for computational intelligence in precision medicine. Machine learning, deep learning, computer vision, natural language processing, multimodal learning, graph neural networks, and foundation models have demonstrated remarkable capabilities in analyzing complex clinical datasets that exceed traditional analytical methods. AI-powered systems are increasingly supporting clinicians through automated tumor detection, molecular characterization, prognostic prediction, radiogenomics, computational pathology, treatment optimization, immunotherapy response prediction, adaptive radiation planning, and intelligent clinical decision support. Furthermore, advances in generative artificial intelligence, federated learning, explainable AI, and cloud computing are accelerating the development of continuously learning oncology ecosystems capable of improving patient outcomes while optimizing healthcare efficiency. Despite these advances, significant challenges remain regarding data quality, interoperability, transparency, algorithmic bias, cybersecurity, ethical governance, and regulatory approval. This review provides a comprehensive overview of AI-powered oncology, highlighting technological foundations, current clinical applications, emerging innovations, and future directions that are shaping the next generation of precision cancer care.[1]